High-level officials from China's National Health Commission and the National Disease Control and Prevention Administration briefed WHO on China's evolving strategy and actions in the areas of epidemiology, monitoring of variants, vaccination, clinical care, communication and R&D.
WHO again asked for regular sharing of specific and real-time data on the epidemiological situation – including more genetic sequencing data, data on disease impact including hospitalizations, intensive care unit (ICU) admissions and deaths – and data on vaccinations delivered and vaccination status, especially in vulnerable people and those over 60 years old.
10673
世卫组织重申了接种疫苗和加强针对于保护高风险人群，避免重病和死亡的重要性。
WHO reiterated the importance of vaccination and boosters to protect against severe disease and death for people at higher risk.
WHO called on China to strengthen viral sequencing, clinical management and impact assessment, and expressed willingness to provide support on these areas, as well as on risk communications on vaccination to counter hesitancy.
WHO has invited Chinese scientists to present detailed data on viral sequencing at a meeting of the Technical Advisory Group on SARS-CoV-2 Virus Evolution on 3 January.
WHO stressed the importance of monitoring and the timely publication of data to help China and the global community to formulate accurate risk assessments and to inform effective responses.
10678
2021年世界患者安全日线上全球会议：“共同实现安全和有尊严的孕产妇和新生儿医疗照护”
World Patient Safety Day 2021 Virtual Global Conference
World Patient Safety Day 2021 is dedicated to “Safe maternal and newborn care”, recognizing the significant burden of avoidable harm that women and newborns are exposed to due to unsafe care, particularly around the time of childbirth.